CorMedix (CRMD) Research & Development (2010 - 2026)
CorMedix's Research & Development came in at $6.68 million for Q2 2026, up 173.7% from $2.44 million a year earlier.
Powered by 
Analysis
CorMedix (CRMD) Research & Development (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, CorMedix reported Research & Development of $22.82 million, up 182.2% year-over-year; for FY2025, it was $19.33 million, up 390.4% from FY2024.
- Research & Development carries a five-year compound annual growth rate of 7.6% (FY2020 to FY2025).
- Going back by year, Research & Development was $3.94 million in FY2024 (-70.0%), $13.16 million in FY2023 (+23.2%), $10.68 million in FY2022 (-18.7%) and $13.13 million in FY2021 (-1.8%).
- The five-year range for quarterly Research & Development is $650,988 (Q2 2024) to $8.6 million (Q4 2025).
- Year-over-year, Research & Development increased in five of the last seven quarters, with growth averaging 233.1%.
- The fastest year-over-year change in Research & Development over five years came in Q3 2025 (growth of 601.1%), and the weakest in Q2 2024 (a decline of 86.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.81 Bn |
| 10 | CorMedix | 609.51 Mn | -43.01 Mn | 77.13 Mn | 6.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.68 Mn |
| Dec 31, 2025 | 8.60 Mn |
| Sep 30, 2025 | 5.10 Mn |
| Jun 30, 2025 | 2.44 Mn |
| Mar 31, 2025 | 3.19 Mn |
| Dec 31, 2024 | 1.73 Mn |
| Sep 30, 2024 | 727,119.00 |
| Jun 30, 2024 | 650,988.00 |
| Mar 31, 2024 | 837,445.00 |
| Dec 31, 2023 | 2.29 Mn |
| Sep 30, 2023 | 2.66 Mn |
| Jun 30, 2023 | 4.79 Mn |
| Mar 31, 2023 | 3.41 Mn |
| Dec 31, 2022 | 2.84 Mn |
| Sep 30, 2022 | 2.34 Mn |
| Jun 30, 2022 | 3.21 Mn |
| Mar 31, 2022 | 2.29 Mn |
| Dec 31, 2021 | 3.24 Mn |
| Sep 30, 2021 | 4.74 Mn |
| Jun 30, 2021 | 2.52 Mn |
API Access
CorMedix Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CRMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CRMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CRMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();